Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00085722 · ClinicalTrials.gov registry record · Phase 1
Joint Injections for Osteoarthritic Knee Pain
A Phase 1 study, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- Phase 1
- Development phase
- 98
- Enrollment target
NCT00085722: Completed Phase 1 study, sponsored by University of Wisconsin, Madison.
NCT00085722 is a Phase 1 study that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 98 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (63% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00085722, a Phase 1 study, has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 98 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether prolotherapy (PrT), a therapy based on injection of a sugar solution in and around the knee, can decrease pain and disability from knee osteoarthritis (OA).
Interventions
- PROCEDURE Dextrose Prolotherapy
- PROCEDURE Saline Prolotherapy
- OTHER At-home physical therapy exercise group
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 98 participants |
| Start Date | 2004-07 |
| Est. Completion | 2016-05-01 |
| Phase | Phase 1 |
What the finished NCT00085722 record still lists
NCT00085722 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 98 participants, a relatively small participant target, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (63% higher).
The record links to 0 conditions, and to 3 interventions - of which Dextrose Prolotherapy is the first listed.
NCT00085722 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00085722 about?
NCT00085722 is a clinical study titled "Joint Injections for Osteoarthritic Knee Pain". The purpose of this study is to determine whether prolotherapy (PrT), a therapy based on injection of a sugar solution in and around the knee, can decrease pain and disability from knee osteoarthritis (OA).
What is the current status of trial NCT00085722?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 98 participants. The study started on 2004-07. Estimated completion is 2016-05-01.
What interventions are being tested in trial NCT00085722?
The interventions under investigation include: Dextrose Prolotherapy (PROCEDURE), Saline Prolotherapy (PROCEDURE), At-home physical therapy exercise group (OTHER).
Who is sponsoring clinical trial NCT00085722?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00085722's enrollment target sits among peer trials
98 592nd of 2000 higher than 1,404 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02926729 · 98 participants · NA
Real-Time Assessment Of Breast Cancer Lumpectomy Specimen Margins With Nonlinear Microscopy
- NCT03382977 · 98 participants · Phase 1
Study to Evaluate Safety, Tolerability, and Optimal Dose of Candidate GBM Vaccine VBI-1901 in Recurrent GBM Subjects
- NCT04577014 · 98 participants · Phase 1
Retifanlimab (Anti-PD-1 Antibody) With Gemcitabine and Docetaxel in Patients With Advanced Soft Tissue Sarcoma
- NCT04817618 · 98 participants · Phase 3
Study of Efficacy and Safety of Iptacopan in Patients With C3 Glomerulopathy.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia